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ORIGINAL ARTICLEAseptic Barriers Allow a Clean Contact for
Contaminated Stethoscope Diaphragms
Rajiv Vasudevan; Ji H. Shin; Jessica Chopyk, PhD; William F. Peacock, MD;
Francesca J. Torriani, MD; Alan S. Maisel, MD; and David T. Pride, MDAbstract
Objective: To determine whether a single-use stethoscope diaphragm barrier surface remains aseptic
when placed on pathogen-contaminated stethoscopes.
Methods: From May 31 to August 5, 2019, we tested 2 separate barriers using 3 different strains of 7
human pathogens, including extended-spectrum b-lactamaseeproducing Escherichia coli, methicillin-
resistant Staphylococcus aureus, and vancomycin resistant Enterococcus faecium.
Results: For all diaphragms with either of the 2 barriers tested, no growth was recorded for any of the
pathogens. Stethoscopes with aseptic barriers remained sterile for up to 24 hours. These single-use barriers
also provided aseptic surfaces when stethoscope diaphragms were inoculated with human specimens,
including saliva, stool, urine, and sputum.
Conclusion: Disposable aseptic diaphragm barriers may provide robust and efficient solutions to reduce
transmission of pathogens via stethoscopes.
ª 2020 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/) n Mayo Clin Proc Inn Qual Out 2020;4(1):21-30From the Departments of
Medicine (R.V., F.J.T.,
A.S.M., D.T.P.) and Pa-
thology (J.H.S., J.C., D.T.P.),
University of California,
San Diego; and Depart-
ment of Emergency Med-
icine, Baylor College of
Medicine, Houston, TX
(W.F.P.).H ealth careeassociated infections(HAIs) pose a significant health riskto acute-care patients,1 especially
when involving susceptible or immunocom-
promised hosts.2,3 According to the Centers
for Disease Control and Prevention, there
were an estimated 687,000 documented
HAIs within the United States in 2015,
responsible for approximately 72,000 deaths.4
These HAIs lead to significant increases in
lengths of stay and hospital costs.5 Annual
direct health care costs attributed to HAIs in
the United States are estimated to be between
$28 billion and $45 billion.6 Hand hygiene in-
terventions have been used extensively to
reduce the transmission of pathogens respon-
sible for HAIs7-10 because physical contact
represents the primary means by which pro-
viders examine their patients and thereby
potentially introduce cross-contamination
and transmit pathogens. However, the stetho-
scope is used in the cardiopulmonary assess-
ment of nearly every patient but has never
been effectively targeted for infection preven-
tion interventions.
Stethoscopes harbor similar levels of mi-
crobial colonization as one’s hand, warrantingMayo Clin Proc Inn Qual Out n February 2020;4(1):21-30 n https:/
www.mcpiqojournal.org n ª 2020 Mayo Foundation for Medical Ed
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-being called the “third hand” of the physi-
cian.11,12 Several pathogens have been discov-
ered on stethoscope diaphragms, including
methicillin-sensitive and methicillin-resistant
Staphylococcus aureus (MRSA), Escherichia coli,
vancomycin-resistant Enterococcus (VRE),
Pseudomonas aeruginosa, and Clostridiodes diffi-
cile.11,13-16 When these bacteria colonize
stethoscope diaphragms, they may be trans-
mitted to the patient’s skin after as few as 3
seconds of contact.17 Typical auscultation pro-
cedures involve several minutes of contact
with the skin and therefore present sufficient
opportunities for pathogen transfers.
Studies have been performed to charac-
terize stethoscope hygiene in clinical settings
to identify obstacles that reduce proper hy-
giene practices. Hygiene rates are estimated
to vary from 10% to 80%18-22 when assessed
by surveys, but the wide variation in these re-
sults likely reflects reporting biases.23 Direct
observational studies report much lower
stethoscope hygiene, in the range of 11% to
16%.24,25 Cited barriers to hygiene perfor-
mance include lack of time and poor access
to disinfecting materials. These barriers persist
despite most providers being aware that/doi.org/10.1016/j.mayocpiqo.2019.10.010
ucation and Research. Published by Elsevier Inc. This is an open access article under
nc-nd/4.0/).
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22stethoscopes can be colonized with microbes
and potentially serve as a vector for
transmission.26
The Centers for Disease Control and Pre-
vention guidelines classify the stethoscope as
a noncritical medical device (ie, in contact
with intact skin, no bodily fluids), for which
they recommend cleaning for at least 1 minute
after each patient interaction using an alcohol-
or bleach-based disinfectant.27 However,
recent literature suggests that common disin-
fectants might not completely eliminate
contaminating bacteria.28 For example, Entero-
coccus faecium demonstrates increasing toler-
ance to 70% isopropyl alcohol solutions29
and may continue to colonize stethoscopes
despite cleaning. This emerging literature
highlights a need for alternatives to alcohol-
and bleach-based stethoscope disinfectants.
In this study, we evaluated 2 different
single-use aseptic barriers to determine their
efficacy in preventing transmission of mi-
crobes that colonize stethoscope diaphragms.
Our goals were to: (1) determine whether
these diaphragms could prevent the transmis-
sion of different types of microbes, including
bacteria and yeasts; (2) examine the period
over which these barriers might prevent trans-
mission; and (3) determine whether theBarrier 1
(B1)
Barrier 2
(B2)
No barrier
control (C)
CB2B1
CB2B1
for determining barrier efficacy in preventing
via stethoscope diaphragms.
Mayo Clin Proc Inn Qual Out n February 20barriers prevent transmission of microbes
from human specimens.
Human subject involvement in this study
was approved by the University of California,
San Diego Administrative Panel on Human
Subjects in Medical Research and was certified
as category 4 exempt, which does not require
informed consent on behalf of the study
participants.METHODS
Cultivation of Microbes
The bacteria used in this study were recovered
from the University of California San Diego
Health Clinical Microbiology Laboratory using
specimens with documented culture results
using standard-of-care clinical microbiology
procedures. Saliva specimens were previously
collected from healthy individuals. Stool was
obtained from individuals being evaluated for
the presence of Helicobacter pylori stool anti-
gen. Urine was collected from individuals
with documented urinary tract infections,
and sputum was collected from individuals
with pathogens, including S aureus, Moraxella
catarrhalis, Haemophilus influenzae, and P aeru-
ginosa in their sputum samples.
The identity of each microbe was
confirmed using the Bruker matrix-assisted
laser desorption time-of-flight assay using the
Research Use Only Database (Brucker Scienti-
fic). Antibiotic susceptibilities for bacteria were
performed on the Becton Dickenson Phoenix
M50 machine (Becton, Dickinson and Co),
which uses the microbroth dilution tech-
nique.30 Cultures of each pathogen were
grown in brain-heart infusion broth to approx-
imately 108 colony-forming unit (CFU)/mL
and diluted to 106 CFU/mL before use in
this study. The Candida albicans was diluted
to 107 CFU/mL because in preliminary
studies, few colonies could be obtained at
106 CFU/mL. Each of these organisms was
an aerobe or facultative anaerobe and was
capable of growing under aerobic conditions;
the exceptions were the anaerobic Bacteroides
species, which were chosen instead of C diffi-
cile to test the barriers’ effectiveness against an-
aerobes. For the Bacteroides species, we
inoculated directly from swabs of the plate
cultures rather than using the broth dilutions.20;4(1):21-30 n https://doi.org/10.1016/j.mayocpiqo.2019.10.010
www.mcpiqojournal.org
ASEPTIC BARRIERS FOR STETHOSCOPEEvaluation of Aseptic Barriers With Human
Pathogens
From May 31, 2019, until August 5, 2019,
three replicate clinical strains of 6 bacteria spe-
cies and 1 yeast were prepared (n¼21 sam-
ples). Four of these species were common
multidrug-resistant (MDR) pathogens: MRSA,
extended-spectrum b-lactamaseeproducing E
coli (ESBL), VRE, and MDR P aeruginosa.
Three other microbes were also tested: Staphy-
lococcus epidermidis, C albicans, and Bacteroides
species. Only fresh cultures (growth <16
hours) were used in this study. We grew the
cultures as detailed and used the dilutions to
inoculate the microbes onto 3 stethoscope di-
aphragms (Medline Industries, Inc) per strain
(n¼54), testing 2 medical-grade aseptic barrier
tapes (Aseptiscope Inc) and 1 no-barrier
control.
We used Copan FLOQswabs (Copan Di-
agnostics Inc), dipped them into the vortexed
diluted cultures, and used them to inoculate
the stethoscope diaphragms (Figure 1). The
diaphragms were allowed to dry for 10 mi-
nutes, then the barriers were subsequently
applied. The diaphragms were then swabbed
with a clean swab, placed into ESwab media,
and planted on blood agar, chocolate agar,
and MacConkey agar (gram-negative selective)
plates using the Copan WASP automated
planting system (Copan Diagnostics Inc). Cul-
tures were incubated at 37C for 24 to 48
hours, and colonies were counted manually.
For Bacteroides species, the plates were
swabbed and the stethoscope diaphragms
were directly inoculated from these swabs
and allowed to dry. The diaphragms were
then swabbed using a clean swab and placed
into ESwab media and planted on the media
types described previously. These plates were
incubated for 48 hours anaerobically using
an Anoxomat Mark II System (Advanced In-
struments Inc), and colonies were counted
manually.Barrier Efficacy With Human Samples
We tested the potential for pathogenic trans-
mission through the barrier from human pa-
tient specimens. Four specimens were used:
saliva previously collected from healthy indi-
viduals, stool from patients being evaluated
for H pylori stool antigen, urine from patientsMayo Clin Proc Inn Qual Out n February 2020;4(1):21-30 n https:/
www.mcpiqojournal.orgwith documented urinary tract infections,
and sputum from patients with S aureus, M
catarrhalis, H influenzae, and P aeruginosa
pneumonia or bronchitis. Microbe identifica-
tion and antibiotic susceptibilities were per-
formed using the mentioned techniques.
Copan FLOQSwabs were dipped directly
into each specimen and used to inoculate the
stethoscope diaphragms according to the
same protocol as bacterial isolates.
Longitudinal Effectiveness of Aseptic
Barriers
In the event that a barrier is applied for an
extended period, we sought to evaluate its
ability to provide aseptic surfaces over time.
We diluted fresh cultures of S epidermidis (a
common bacterium found on the skin) to
107 CFU/mL and inoculated the stethoscope
diaphragms with a swab of the culture. After
the diaphragms were dried, stethoscopes
were either kept without barriers (n¼3) or
had a barrier placed, with both barriers being
tested (n¼6). After 5 separate trials with pe-
riods of 15 minutes, 30 minutes, 2 hours, 4
hours, and 24 hours, we used FLOQswabs
to swab the diaphragms and planted the cul-
tures on blood agar and chocolate agar plates
using the WASP automated planting system.
Cultures were incubated aerobically at 37C
for 24 hours and colonies were counted
manually.
Controls in these experiments involved
direct inoculation of the bacterial preparations
onto media using the WASP automated
planting system. For the individual bacteria
and yeast experiments, we tested 3 replicates
of 2 aseptic barriers for a total of 6 total repli-
cates. We combined the replicates because
there were no microorganisms recovered
from any of the barriers. For experiments us-
ing specimens of stool, saliva, sputum, and
urine, we tested 5 replicates on 2 different bar-
riers for a total of 10 replicates. An additional
control was performed by swabbing barriers
with microbes to discern whether barriers pro-
vide a physical hindrance to microbe transmis-
sion or they had direct antimicrobial activity.
Statistical Analyses
Statistical analyses were performed in RStudio,
version 1.0.153. Differences in colony counts
between stethoscope diaphragms with and/doi.org/10.1016/j.mayocpiqo.2019.10.010 23
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FIGURE 2. Bar charts represent mean colony counts  standard error for
Staphylococcus epidermidis on stethoscope diaphragms across time. Colonies
were counted for S epidermidisecolonized diaphragms without disc barriers
(B) and stethoscope diaphragms with disc barriers (Bþ). The y-axis rep-
resents mean colony counts, and the x-axis represents the conditions and
times that S epidermidis was placed on diaphragms before plating. Colony
counts on (A) sheep blood agar plates and (B) chocolate agar plates. For Bþ
stethoscope diaphragms, no colonies were recovered on any plate types
regardless of time period. *Values that are statistically significant (P.05)
comparing colony counts with (Bþ) and without (B) disc barriers using a 1-
tail t-test.
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24without barriers were determined using 1-tail t
tests. In addition, analysis of variance with
post hoc Tukey honestly significant differenceMayo Clin Proc Inn Qual Out n February 20tests were used to compare colony counts
from stethoscope diaphragms with barriers,
without barriers, and with barrier controls.
RESULTS
Longitudinal Assessment of Aseptic
Barriers
We evaluated the ability of the barriers to
remain aseptic at several time points up to
24 hours. We were able to cultivate S epidermi-
dis from the diaphragms without barriers reli-
ably at 15 minutes, 30 minutes, 1 hour, 4
hours, and 24 hours (Figure 2) and tested
the difference in colony counts using a 1-
tailed t test. At each time point, there was sig-
nificant (P.05) growth of S epidermidis on the
stethoscope diaphragms without the barriers,
but no growth on the diaphragms with the
barriers.
Barriers Protect Against Aerobic/Facultative
Anaerobic Pathogens
We tested the efficacy of the aseptic barriers
against 5 bacteria and 1 yeast. We cultivated
each of these pathogens on blood and choc-
olate agar plates, but also grew them on
MacConkey agar, which is selective for
gram-negative pathogens such as P aerugi-
nosa and E coli. We observed identical trends
on blood agar and chocolate agar plates
(Figure 3A and B), on which there was sig-
nificant growth of each of the 6 pathogens
without the barriers, but no growth when
the barriers were applied. Using analysis of
variance with a post hoc Tukey honestly sig-
nificant difference test, we found that these
results were significant (P.05) for 5 of 6
pathogens on blood agar and 4 of 6 patho-
gens on chocolate agar. On the MacConkey
agar, only the E coli and P aeruginosa grew,
but they demonstrated the same significant
results observed on the other media types,
on which there was pathogen growth
without barriers, but none when barriers
were present (Figure 3C). When microbes
were placed on top of the barriers, they
were capable of growing on the barrier sur-
face in all circumstances, suggesting that
the barriers provided physical but not
directly antimicrobial activity against
contaminating pathogens (Figure 3). These
data demonstrate that aseptic barriers20;4(1):21-30 n https://doi.org/10.1016/j.mayocpiqo.2019.10.010
www.mcpiqojournal.org
300 *
250
200
Co
lo
ny
 c
ou
nt
Microbe and conditions
Blood agar
150
100
50
0
Ctrl B– BC
C albicans S epidermidis ESBL E coli P aeruginosa MRSA VRE
B+ Ctrl B– BC B+ Ctrl B– BC B+ Ctrl B– BC B+ Ctrl B– BC B+ Ctrl B– BC B+
* * * *
* * * *
A
300
250
200
Co
lo
ny
 c
ou
nt
Microbe and conditions
MacConkey agar
150
100
50
0
Ctrl B– BC
C albicans S epidermidis ESBL E coli P aeruginosa MRSA VRE
B+ Ctrl B– BC B+ Ctrl B– BC B+ Ctrl B– BC B+ Ctrl B– BC B+ Ctrl B– BC B+
* *
* *
C
300
250
200
Co
lo
ny
 c
ou
nt
Microbe and conditions
Chocolate agar
150
100
50
0
Ctrl B– BC
C albicans S epidermidis ESBL E coli P aeruginosa MRSA VRE
B+ Ctrl B– BC B+ Ctrl B– BC B+ Ctrl B– BC B+ Ctrl B– BC B+ Ctrl B– BC B+
* * * *
* * * *
B
Without barrier (B–)
Barrier control (BC)
With barrier (B+)
Control (Ctrl)
FIGURE 3. Bar charts represent mean colony counts  standard error for microbes on stethoscope diaphragms. Colonies were
counted for control (Ctrl) microorganisms (directly plated from broth), colonized diaphragms without disc barriers (B), disc barriers
colonized with microorganisms (BC), and stethoscope diaphragms with disc barriers (Bþ). The y-axis represents mean colony counts,
and the x-axis represents the individual microbes and conditions by which diaphragms were treated. Colony counts on (A) sheep
blood agar plates, (B) chocolate agar plates, and (C) MacConkey agar plates. C albicans ¼ Candida albicans, S epidermidis ¼ Staph-
ylococcus epidermidis, ESBL E coli ¼ extended-spectrum b-lactamaseeproducing Escherichia coli, P aeruginosa ¼ Pseudomonas aeru-
ginosa, MRSA ¼ methicillin-resistant Staphylococcus aureus, VRE ¼ vancomycin-resistant Enterococcus faecium. For Bþ stethoscope
diaphragms, no colonies were recovered for any microorganisms on any plate types. *Values that are statistically significant (P.05)
comparing colony counts with disc barriers (Bþ), without disc barriers (B), and with barrier controls (BC) using analysis of variance
with post hoc Tukey honestly significant difference.
ASEPTIC BARRIERS FOR STETHOSCOPEprovide an aseptic surface to reduce poten-
tial transmission of microbes that contami-
nate stethoscope diaphragms.
Utility of Barriers Against Anaerobes
We also tested whether barriers provided
aseptic surfaces against stethoscope surfaces
contaminated with anaerobic bacteria. We
examined 3 separate species of Bacteroides inMayo Clin Proc Inn Qual Out n February 2020;4(1):21-30 n https:/
www.mcpiqojournal.orgour evaluation. Each of these species grew
well under anaerobic conditions on stetho-
scope diaphragms, but none grew in the pres-
ence of the barriers (Figure 4). Using a 1-tailed
t test, colony counts were significantly greater
(P.05) without barriers. These results indi-
cate that aseptic barriers may prevent trans-
mission of anaerobic bacteria on stethoscope
diaphragms./doi.org/10.1016/j.mayocpiqo.2019.10.010 25
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FIGURE 4. Bar charts represent mean colony counts  standard error for
Bacteroides species on stethoscope diaphragms. Colonies were counted for
control (Ctrl) Bacteroides species (directly plated from broth), colonized
diaphragms without disc barriers (B), and stethoscope diaphragms with
disc barriers (Bþ). The y-axis represents mean colony counts, and the x-axis
represents media types and conditions by which stethoscopes were treated.
For Bþ stethoscope diaphragms, no colonies were recovered on any plate
types. *Values that are statistically significant (P.05) comparing colony
counts with (Bþ) and without (B) disc barriers using a 1-tail t test.
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26Evaluation of Aseptic Barriers With Human
Specimens
We found that for saliva, colony counts from
diaphragms without barriers were significantly
greater (P.05) than from stethoscopes with
aseptic barriers (Figure 5A) for both the choc-
olate and blood agars. We identified the same
significant (P.05) trend when diaphragms
were inoculated with stool (Figure 5B) for all
media types tested. Similar results were ob-
tained for urine (Figure 5C) and sputum
(Figure 5D), on which no growth was recov-
ered from diaphragms with barriers. However,
the data for urine and sputum did not meet
statistical significance secondary to the large
variation that was observed in colony counts
across the 5 different urine and sputum spec-
imens tested.
In saliva, we identified only bacteria
capable of growing on blood and chocolate
agar plates (Figure 5A). These bacteria
included various species of Streptococcus,
Rothia mucilaginosa, and some oral Neisseria
species (Table). In stool, we identified mi-
crobes that grew on all media typesMayo Clin Proc Inn Qual Out n February 20(Figure 5B). We found Streptococcus gallolyti-
cus, various Enterococcus species, Weissella
cibaria, and many Enterobacteriaceae family
members, including Klebsiella pneumonia, E
coli, Raoultella ornithinolytica, and Citrobacter
freundii. Bacteria in the urine that grew on
all media types (Figure 5C) included various
Enterococcus species, K pneumoniae, E coli,
and P aeruginosa. We also isolated bacteria
from sputum-inoculated diaphragms on all
media types (Figure 5D), including Strepto-
coccus parasanguinis, R mucilaginosa, Abiotro-
phia defectiva, Granulicatella adiacens, S
aureus, M catarrhalis, H influenzae, and P aer-
uginosa. These data indicate that aseptic bar-
riers can prevent the transmission of a large
variety of microbes from stethoscope dia-
phragms to patients.
DISCUSSION
We tested 2 separate barriers against a range of
potentially transmissible antibiotic-resistant
and pathogenic microbes to determine their
efficacy in reducing pathogen transmission.
Our results were comprehensive in that both
barriers prevented the growth of anaerobes,
antibiotic-resistant bacteria, yeasts, and body
samples, including saliva, stool, urine, and
sputum. While we specifically evaluated
VRE, MRSA, ESBL E coli, and MDR P aerugi-
nosa to demonstrate the potential role in
reducing the transmission of antibiotic-
resistant bacteria, we also tested other mi-
crobes in S epidermidis, Bacteroides species,
and C albicans (Figures 3 and 4). None of
these organisms grew in the presence of the
aseptic barriers. We observed this same phe-
nomenon from samples of saliva, stool, urine,
and sputum in which microbes were unable to
grow in the presence of barriers (Table;
Figure 5). These results strongly suggest that
barriers prevent the transmission of most if
not all bacteria and yeasts that might contam-
inate stethoscope diaphragms.
Because it is now recognized that stetho-
scope hygiene is another weakness in hospi-
tal infection prevention practices,13 we
evaluated the role that aseptic barriers could
play in reducing the transmission of mi-
crobes. We used medical-grade aseptic bar-
riers that do not affect the subjective quality
of auscultation while still providing physical
protection from microbes. These barriers are20;4(1):21-30 n https://doi.org/10.1016/j.mayocpiqo.2019.10.010
www.mcpiqojournal.org
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FIGURE 5. Bar charts represent mean colony counts  standard error of bacteria from human specimens contaminating stethoscope
diaphragms: (A) saliva, (B) stool, (C) urine, and (D) sputum. Colonies were counted for control (Ctrl) specimens (directly plated from
the specimen), colonized diaphragms without disc barriers (B), and stethoscope diaphragms with disc barriers (Bþ). The y-axis
represents mean colony counts, and the x-axis represents media types and conditions by which diaphragms were treated. For Bþ
stethoscope diaphragms, no colonies were recovered for any specimen types on any plate types. *Values that are statistically sig-
nificant (P.05) comparing colony counts with (Bþ) and without (B) disc barriers using a 1-tail t test.
ASEPTIC BARRIERS FOR STETHOSCOPEsingle use and applied to the stethoscope dia-
phragm using a sterile hands-free dispenser
just before evaluating the patient, thus
ensuring hygienic patient contact similar to
disposable gowns/gloves. Their potential ben-
efits include reduced transmission of patho-
genic and antibiotic-resistant microbes and
potentially improved auscultation in the pul-
monary and cardiac physical examination
compared with the current standard of care
in high-acuity settings in which single-
patient stethoscopes are used.31Mayo Clin Proc Inn Qual Out n February 2020;4(1):21-30 n https:/
www.mcpiqojournal.orgAlthough other solutions to stethoscope
hygiene have been promoted, they have eli-
cited ambiguous results. One study imple-
mented visual reminders for stethoscope
hygiene and alcohol-swab baskets in hospital
wards and reported an increase in the rate of
stethoscope cleaning from 34% to 59%.32
Another implemented a similar protocol in
addition to providing informational lectures
to the medical staff and observed no compli-
ance (0%) either before or after the
intervention.33/doi.org/10.1016/j.mayocpiqo.2019.10.010 27
TABLE. Microbes Recovered on Stethoscope Diaphragms
Saliva Stool Urine Sputum
Streptococcus oralis
Streptococcus
parasanguinis
S parasanguinis
Streptococcus mitis
Streptococcus
gallolyticus
Abiotrophia defectiva
Granulicatella adiacens
Rothia mucilaginosa R mucilaginosa
Weissella cibaria
Staphylococcus aureus
Enterococcus
faecalis
E faecalis
Enterococcus
avium
E avium
Enterococcus
gallinarum
Neisseria subflava
Neisseria flavescens
Moraxella catarrhalis
Haemophilus influenza
Klebsiella pneumoniae K pneumoniae
Escherichia coli E coli
Raoultella ornithinolytica
Citrobacter freundii
Pseudomonas
aeruginosa
P aeruginosa
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28Alternatively, stethoscope hygiene solu-
tions have been described. One study
evaluated the antimicrobial properties of
a copper-alloy metal stethoscope, citing
decreased levels of contamination; however,
it did not mention the cost implementing
such a change.34 Another investigated a
stethoscope UV-light case, but reported
incomplete decontamination.35 An additional
study investigated an antimicrobial stetho-
scope coating.36 Such a coating might select
for resistant microorganism stethoscope colo-
nization. Our study demonstrated the effec-
tiveness of an aseptic diaphragm barrier
without antimicrobial properties (Figure 3)
to limit the formation and propagation of
resistant pathogens. Because the barriers are
disposable, are single-use, and work by
providing a physical rather than antimicrobial
barrier, they provide protection without theMayo Clin Proc Inn Qual Out n February 20risk for resistant microorganisms. Although
prior technologies have accomplished only a
partial reduction in stethoscope contamina-
tion, our data support that the diaphragm bar-
riers are capable of remaining aseptic against a
variety of pathogens.
As we learn about the microorganisms
that inhabit our bodies and environment,
we find that microbes are constantly shared
between individuals and their surround-
ings.37 In the hospital environment, our level
of concern should increase,38 in part because
many antibiotic-resistant and pathogenic mi-
crobes are in the hospital for which exposure
to a susceptible host can have serious conse-
quences. Thus, it is important to recognize
the routes by which microbes are shared in
the hospital and work to limit the potential
for transmission.39 Efforts to limit the trans-
mission of MDR organisms (MDROs) include
the use of contact precautions, strict hand
hygiene, and wearing disposable gowns and
gloves when they come into contact with pa-
tients who are colonized or infected with
MDROs to limit the possibility of transfer
to other patients.40 This process is effective41
but places a limitation on the physical exam-
ination auscultation via stethoscope. Health
care providers (HPs) are provided with
single-patient disposable stethoscopes when
in contact with patients identified with an
MDRO. Unfortunately, the audio quality of
these stethoscopes is poor,31 causing HPs
to sometimes abandon their use in favor of
using their own stethoscopes. This results
in contamination of the HP’s stethoscopes
with MDROs that can be transmitted to
other patients upon subsequent use.17 In
addition, one study found that single-
patient stethoscopes can be colonized by
MDRO bacteria such as MRSA.22 This can
put patients who are in contact precautions
at significant risk for acquiring an HAI.
Another important issue that contributes to
the spread of pathogenic microbes is that
many patients are colonized or infected
with pathogens that are not yet known to
their HPs.42 Under these circumstances,
HPs use their own stethoscopes and un-
knowingly transmit these microbes between
patients, with transfer occurring when the
contaminated stethoscope comes in direct
contact with the patient.1720;4(1):21-30 n https://doi.org/10.1016/j.mayocpiqo.2019.10.010
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ASEPTIC BARRIERS FOR STETHOSCOPECONCLUSION
Stethoscope diaphragm barriersmay reduce the
transmission of pathogens, including MDROs,
during examinations. While most hospitals
use disposable stethoscopes in the presence of
MDROs, the quality of these products can
significantly affect the quality of the physical ex-
amination. Single-use disposable barriers hold
the promise of providing high-quality ausculta-
tion while significantly reducing the potential
for pathogen transmission.Abbreviations and Acronyms: B = colonized di-
aphragms without disc barriers; Bþ = stethoscope di-
aphragms with disc barriers; BC = disc barriers colonized
with microorganisms; CFU = colony-forming unit; Ctrl =
control; ESBL = extended-spectrum b-lactamaseepro-
ducing Escherichia coli; HAI = health careeassociated infec-
tion; HP = health care provider; MRSA = methicillin-
resistant Staphylococcus aureus; MDR = multidrug resistant;
MDRO = multidrug-resistant organism; VRE = vancomycin-
resistant Enterococcus
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